Founder of Meabco A/S in 2001 and Angel investor. Life long experience in commercial start ups.
Prof. Svend Aage EngelholmOncology and Radiation Oncology
Professor Svend Aage Engelholm, MD., D.MSci, University of Copenhagen.
Published more than 250 papers in peer-reviewed journals
Prof. Stig LarsenClinical Research & Development
Professor, DSc. at the Norwegian University of Life Science and has published more than 300 papers in international medical and clinical research methodological journals.
Prof. Henrik HarlingOncology
Associate Professor of Surgery, MD., D.MSci, University of Copenhagen. More than 110 papers in surgical and oncological journals with peer-review.
Peter UlvskjoldEVP and COO
Peter holds a M.Sc. from Aarhus University, School of Business and Social Studies and Harvard University. Peter has 17 years experience in Novo Nordisk, where he has worked in senior positions Denmark and abroad.
Sergey holds a PhD in International Economy and has 17 years of experience in managing multinational research and development projects (nonclinical, clinical, cmc).
Henning ArboeAdministration & Project Manager
Henning has extensive practical experience in HR, and has worked as Manager for several international companies.
Helen SchierbeckVP Business Development
Helen holds a M.Sc. in Biochemistry from the University of Copenhagen.
Helen has 25 years experiences in leading international commercial positions in companies like Novo Nordisk, Dupont, Agilent and Chr. Hansen.
Andrey PanchenkoNonclinical Research
Andrey holds a degree of Medical Doctor from Pavlov Saint Petersburg State Medical University, PhD in pathophysiology and oncology.
More than 50 papers in medical journals in the field of pathology and oncology.
Tea Kirkegaard NielsenResearch & Development
PhD and M.Sc. Molecular Biology
Experienced Research And Development Scientist with a demonstrated history of working in the Research and Pharmaceutical industry.
Bent Østergaard is the CEO of Lauritzen Fonden (LF) and was previously chairman of DFDS and J. Lauritzen. Lauritzen Fonden is parent company of the shipping companies J. Lauritzen (wholly owned) and DFDS (42,5% holding), as well as the private limited company LF Investment ApS (formerly Vesterhavet A/S and J. Lauritzen Holding A/S). LF Investment has holdings in companies in the oil analysis, measuring equipment, software, biotechnology and real estate sectors.
Hans Carl, PhD, Secretary and former Chairman of Meabco, Chairman or board member of several companies and associations including chairman of an anti-cancer association. Regional coordinator of the French association on research of the side effects of radiation exposure. Former director in UNCTAD, the United Nations Conference on Trade and Development.
Niels Boel SørensenMember
Cand.scient.pol., chairman of Kontiki Holding and an experienced investor in a number of companies. Niels Sørensen is on the board of 12 companies and has been on the Meabco Board since 2008.
Philip Nyholm is a transactional / corporate lawyer and Managing Partner at DANDERS & MORE law firm. Philip Nyholm focuses on stock market law, company law, M&A as well as general commercial advice. Through a number of years, Philip has also been involved with several biotech companies and the challenges faced by this type of company.
Linda Sjöström is an experienced senior executive in the pharmaceutical industry and investment partner in the venture capital industry investing in and developing biotech companies with the aim of an IPO or sale to industrial partners. Linda has acted as chairmen and board member in numerous Boards of Directors in DK, Europe and the US. Linda is educated as Master of Science in Chemical Engineering.